Skip to Main Content
Clinical Trials at Yale
YSM Home

INFORMATION FOR

Diseases of the Digestive System - Liver | Diseases of the Digestive System - Pancreas, Phase I-II

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

What is the purpose of this trial?

This study is a Phase 2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-104. The study consists of a 120 day primary study followed by a 20 month long-term safety and durability of response follow-up period.

  • Trial with
    COUR Pharmaceutical Development Company, Inc.
  • Ages
    18 years - 75 years
  • Gender
    Both
Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Suzie Christopher

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

  • Last Updated
    04/21/2023
  • Study HIC
    #2000033749

Contact Information

For more information about this study, including how to volunteer, contact Suzie Christopher